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ABSTRACT 
Background: Surgical site infections are potential complications associated with a type of surgical procedure. Although surgical site infections 
are among the most preventable healthcare associated infections, they still represent a significant burden in terms of morbidity, mortality and 
addition costs to healthcare systems and service payers worldwide. Appropriate antibiotic prophylaxis has shown to be effective in reducing the 
incidence of surgical site infections. 
Aim: The aim of the study is to carry out an evaluation of the risk factors and prophylactic antibiotics used to prevent surgical site infection in 
surgeries performed in an NABH accredited quaternary care hospital in Bengaluru, Karnataka. 
Objective: To evaluate patient related risk factors contributing to the incidence of surgical site infection. To evaluate the prophylactic anti-biotic 
used in the prevention of post-operative surgical site infection and to determine the incidence of surgical site infection. 
Methodology: Subjects who meet the study criteria will be enrolled in the study. Collection of patient related data with subsequent identification 
and evaluation of risk factors and prophylactic anti-biotics, and calculation of incidence of surgical site infection using statistical analysis. 
Results: In this study, on observation of 372 surgical cases, it was estimated that 1 in 10 patients acquired Surgical Site Infection within 30 days 
post-surgery. 
Conclusion: Conclusively, it can be said that the incidence of surgical site infection varies by different patient and procedure factors as well as 
prophylactic anti-biotic properties. They particularly show greater association to age, gender, certain comorbidities (like diabetes mellitus, 
chronic lung disease, and renal insufficiency), and duration of surgery, administration of prophylactic antibiotic, frequency, timing and dose. 
Therefore, greater care must be taken for every specific patient and procedure and also choice of antibiotic prophylaxis. 
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INTRODUCTION 
Surgical site infections (SSIs) are defined 
as infections occurring up to 30 days after surgery (or up to 
one year after surgery in patients receiving implants) and 
affecting either the incision or deep tissue at the 
operation site. SSIs are potential complications associated 
with any type of surgical procedure. SSIs are the third (14-
16%) most frequent cause of nosocomial infections among 
hospitalized patients, and the primary (40%) cause of 
nosocomial infection in surgical patients. Although SSIs are 
among the most preventable HAIs1,2, they still represent a 
significant burden in terms of patient morbidity and 
mortality and additional costs to health systems and service 
payers worldwide (3-11). SSI is both the most frequently 
studied and the leading HAI reported hospital-wide in 
LMICs3,4. For these reasons, the prevention of SSI has 
received considerable attention from surgeons and 
infection control professionals, health care authorities, the 
media and the public. In particular, there is a perception 
among the public that SSIs may reflect a poor quality of 
care. 
The surveillance of HAI is one of the core components of an 
effective healthcare programme1,2. Surveillance is defined 
as “the ongoing, systematic collection, analysis, 
interpretation and evaluation of health data closely 
integrated with the timely dissemination of these data to 
those who need it”. However, defining, detecting, reporting 
and interpreting HAI, including SSI, is challenging and 
requires expertise, time and resource dedication. The 
primary aim of surveillance is the collection of data on SSI 
rates in order to obtain a measure of the magnitude of the 
problem. These data must then be analysed to identify and 
investigate trends, including a careful interpretation of 
results. Finally, surveillance data should guide the 
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identification of improvement actions and evaluate the 
effectiveness of these interventions. In this context, the 
feedback of SSI rates to relevant stakeholders is important. 
The importance of post-discharge surveillance it is 
estimated that a significant proportion of SSIs are detected 
following patient discharge. This proportion varies across 
settings and according to different definitions, but it has 
been estimated to be between 13 to 71% (25). The fact that 
hospital length of stay has been steadily decreasing over the 
past decades has probably contributed to shifting the 
burden from inpatient to outpatient infections. 
Monitoring the incidence of surgical site infections is 
hampered by the lack of agreed measuring systems. In 
particular, to monitor the rates of surgical site infection 
within an organisation, or to benchmark between 
organisations, there needs to be a standard approach to 
diagnosis. Criteria for such a definition have been 
developed by the Centres for Disease Control and 
Prevention (CDC). More detailed surgical site infection 
scoring systems have been developed but these are time 
consuming to use. 
Traditionally, the risk for SSIs has been stratified by 
surgical procedure in a classification system developed by 
the National Research Council (NRC; Table 127–1).The NRC 
classification system proposes that the risk of an SSI 
depends on the microbiology of the surgical site, presence 
of a pre-existing infection, likelihood of contaminating 
previously sterile tissue during surgery, and events during 
and after surgery5,6. A patient’s NRC procedure 
classification is the primary determinant of whether 
antibiotic prophylaxis is warranted. However, because a 
patient’s NRC wound classification is influenced by surgical 
findings (e.g., gangrenous gallbladder) and perioperative 
events (e.g., major technique breaks), categorization 
generally occurs intraoperatively7. 
According to the Centers for Disease Control and 
Prevention’s (CDC) National Nosocomial Infections 
Surveillance System (NNIS), 3 SSIs can be categorized as 
either incisional (e.g., cellulitis of the incision site) or 
organ/space (e.g., meningitis). Incisional SSIs are 
subcategorized into superficial (involving only the skin or 
subcutaneous tissue) and deep (fascial and muscle layers) 
infections. Organ/space SSIs can involve any anatomic area 
other than the incision site. For example, a patient who 
develops bacterial peritonitis after bowel surgery has an 
organ/space SSI. By definition, SSIs must occur within 30 
days of surgery8,9. 
Many surgical site infections, for example, those involving 
prosthetic joints, often develop late (>28 days post-
operation), so post-discharge surveillance schemes are 
essential. Patients need to be aware how a surgical site 
infection may present after discharge from hospital. 
Surveillance of surgical site infections and feedback to the 
surgical team has been shown to reduce rates of 
infection10,11. 
Risk factors: 
Whether a wound infection occurs after surgery depends on 
a complex interaction between the following: 
Procedure-related factors: Implantation of foreign bodies, 
degree of trauma to host tissues, duration of the surgery, 
type of the surgery, type of the surgical wound and 
experience of surgeon. 
Patient-related factors: Host immunity, nutritional status 
and the presence or absence of diabetes, chronic lung 
disease, social habits (smoking and alcohol). 
Microbial factors: Tissue adherence and invasion. 
Peri-operative antimicrobial prophylaxis: Appropriate 
anti-biotic, dose, frequency of dosing, time the dose was 
given. 
Prosthetic implants: Medical implants have a detrimental 
effect on host defences such that a lower bacterial count is 
needed to initiate infection. Hence, there is a greater risk of 
infection during implant surgery. Bacteria growing on an 
abiotic surface, such as a prosthetic hip implant or heart 
valve, together with a protective layer of microbial 
polymers are known as a biofilm. Anti-microbials are 
frequently ineffective against micro-organisms growing in 
biofilms, making treatment of implant infections 
problematic and their prevention even more important. 
Duration of surgery: The longer the operation, the greater 
is the risk of wound infection. This, in turn, may be 
influenced by the experience (Fig. 39.2) speed and skill of 
the surgeon and is additional to the classification of the 
operation by risk of infection, for example, clean, 
contaminated, dirty or infected. 
Patient related factors: A number of patient related 
factors are known to influence the likelihood of developing 
a surgical site infection and include the following: 
Wound potential for infection, for example, clean, 
contaminated, dirty or infected site. 
Physical status of patient 
Smoking: Smoking increases the risk of developing a 
wound infection. The mechanism is not known but tobacco 
use may delay wound healing via the vasoconstricting 
effects of nicotine and thus increase the risk of infection. 
Diabetes mellitus: Long-term diabetes does not appear to 
have any impact on the risk of developing a surgical site 
infection. However, perioperative fluctuations in blood 
glucose for up to 48 h have been shown to double the 
infection risk in cardiac patients. 
Age: Increasing age is associated with an increased risk of 
surgical site infection. However, there is debate whether 
age serves simply as a marker for underlying disease or 
whether the decline in immune function with age is the 
significant factor. A study of 72,000 patients in the USA, 
which adjusted for hospital type, procedure, duration, 
wound class and physical status of the patient, showed a 
1.1% increase in surgical site infection per year of age from 
the age of 18 to 65 years, but a 1.2% decrease in individuals 
over 65 years. In contrast, the findings of the English 
surgical site infection surveillance scheme indicated that 
the chance of getting a surgical site infection were 37% 
higher for a 65-year-old person compared to a 45-year-old 
person. 
Preoperative immunosuppression: Corticosteroid use 
may increase infection risk. 
Malnutrition: It is a well-described risk factor for 
postoperative complications, including SSI, impaired wound 
and colonic anastomosis healing, and prolonged hospital 
stay. Although enteral feeding during the perioperative 
period can reduce bacterial translocation by maintaining 
the integrity of the intestinal mucosa, nutritional 
supplementation does not decrease the incidence of 
infection. 
Objectives 
 To evaluate patient related risk factors contributing to 
the incidence of surgical site infection. 
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 To compare with antimicrobial prophylactic guidelines 
of the Hospital, ICMR, and IDSA with the antimicrobials 
prescribed pre- operatively, peri-operatively and post- 
operatively. 
 To evaluate the prophylactic antibiotic used in the 
prevention of post-operative surgical site infection. 
 To determine incidence of surgical site infection. 
MATERIALS AND METHODS 
Study site: 
The study was conducted in an NABH accredited 
Quaternary Care Hospital, Bengaluru, Karnataka, India. 
Study design: 
A prospective hospital-based observational study. 
Study duration: 
The study was conducted for a period of six months. 
Study criteria: 
Inclusion criteria 
 Subjects of any age undergoing open surgery (clean to 
dirty contaminated wounds) 
 Subjects of only elective surgeries are considered. 
 Surgeries from departments such as-Gastroenterology, 
General surgery, Orthopedic, Plastic surgery, 
Neurology, Obstetrics and Gynecology, Urology, 
Oncology, Cardiovascular are considered. 
Exclusion Criteria 
 Topical antibiotics 
 Antibiotics administered as treatment for known 
infections are not considered. 
 Transplants, micro-surgeries and laser surgeries. 
 Emergency and trauma cases were not collected. 
Source of Data 
Patient profile form 
The patient profile form was self-designed in accordance with the 
required information for the study. The form consisted of four 
broad categories: Patient related information; Pre-operation 
details; Surgery related details and Post-operative details. 
Patient related details 
This part of the patient profile form consists of patient details 
including patient name, gender, age, weight in kg, height in cm, 
date of admission, date of discharge, unique health identification 
number (UHID), in-patient number (IP), contact details, patient 
residential location, current medical diagnosis, medical history 
and allergies if any, medication history, social history like 
smoking, alcohol use or others, presence of any risk factors such 
as age, obesity, anaemia or presence of any co-morbidities such as 
diabetes mellitus; chronic lung disease; immunosuppressed 
status; renal insufficiency etc. 
Pre-operation details 
Preoperative details include laboratory data collected prior to the 
surgery, blood glucose levels, blood pressure, presence of 
antimicrobial prophylaxis, if yes- choice of antibiotic, dose of the 
administered drug, route of administration, time of 
administration, frequency of administration and comparison of 
the administered drug to antimicrobial guidelines. 
Surgery related details 
Surgery details include type and department of surgery, date and 
time of surgery, history of surgery if any, wound type- clean; 
clean-contaminated; contaminated; dirty, duration the of surgery, 
use if implants if any, and any other required information. 
Post-operative details 
This section includes information regarding use of any 
antimicrobial therapy post surgery, post-operative medications 
during the hospital stay and discharge medications. 
Questionnaire 
The follow-up patient data was collected in a well-designed 
“Surgical wound healing post- discharge Questionnaire”, 
Public health England (permission taken). Data was 
obtained over the call after period of 30 days from either 
the patient or the care taker. 
The questionnaire consists of patient details such as-Name 
of the patient, UHID number, date of the admission, 
category of surgery and date of the surgery. Followed by the 
patient details, a series of questions are included in the 
questionnaire pertaining to presence or absence of various 
signs and symptoms due to the infection in case of presence 
of a surgical site infection. The questions are designed to 
attain information regarding: 
 Discharge or leakage of any kind from the site of 
surgery. 
 Presence of any other kind of symptoms such as pain 
or soreness at the sight, redness or inflammation, 
erythema, swelling, gaped openings at wound site. 
 Consultation post infection to any health care service 
providers 
 Details of any antibiotics prescribed post SSI. 
The questionnaire also consists of a SSI surveillance 
categorizing the symptoms into 4 categories that are: 
1) Criteria 1- discharge pus + antibiotics prescribed. 
2) Criteria 2-clinical signs*+dehiscence. 
3) Criteria 3-clinical signs*+antibiotics prescribed. 
4) Criteria 4- Not applicable (includes only single symptom) 
*Clinical signs-at least 2 of pain, heat, redness, or swelling. 
Procedure 
 Data was collected prospectively from those surgical 
cases that met the study inclusion criteria. 
 Required data was collected into the patient profile 
form and the case was followed up until patient was 
discharged. 
 The data obtained is thoroughly reviewed and the 
antimicrobial drug administered is compared to 
antimicrobial guidelines such as the hospital 
antimicrobial guidelines, IDSA guidelines, ICMR 
guidelines and the WHO antimicrobial prophylaxis 
guidelines. 
 The post-operative medication and the discharge 
medication are reviewed for drug interactions that 
may interfere with the action of the prescribed anti-
biotic. 
After a period of 30 days, the patient was contacted on their 
provided contact details  for collection of the follow up data. 
 Shenoy et al                                                                                                        Journal of Drug Delivery & Therapeutics. 2019; 9(2-s):159-166 
ISSN: 2250-1177                                                                                  [162]                                                                                 CODEN (USA): JDDTAO 
 The follow up data was collected on a questionnaire 
that was collected from the “Surgical wound healing 
post-discharge questionnaire” Health agency, London. 
 The patients who were infected at the surgical site 
were questioned regarding the signs and symptoms 
that they were experiencing and information regarding 
post infective medical care was also collected. 
 After the data collection was complete, the total 
number of infected cases was estimated. 
 Every patient that experienced an SSI was reviewed 
thoroughly to study the risks that may have 
contributed to the occurrence of the infection at the 
surgical site. 
 Following the review of risk factors, the incident rate 
of the infection was calculated. 
The patients that reported an SSI were categorized into 
criteria based on Public Health England (PHE) scoring. The 
criteria were: 
1) Criteria 1- discharge pus + antibiotics prescribed 
2) Criteria 2-clinical signs*+dehiscence 
3) Criteria 3-clinical signs*+antibiotics prescribed 
4) Criteria 4- Not applicable (includes only single symptom) 
*Clinical signs-at least 2 of pain, heat, redness, or swelling. 
The data collected, and the incident rate was graphically 
represented. 
RESULTS 
Total of 372 subjects were collected out of which 36 (10%) 
acquired surgical site infection. 372 surgical cases were 
collected from various surgical departments. 
 
Figure 1: Distribution of surgical cases in various 
departments 
 
Figure 1 shows distribution of surgical cases in various 
departments. The 36 infected surgical cases were 
categorized based on various risk factors. 
The risk factors are divided into as follows: 
Patient related factors 
The various patient related factors include sex, age, co-
morbidities, and social habits. 
Sex 
Out of 36 infected surgical cases, 20 belonged to male 
category while 16 belonged to the female category. 
Age 
Age was categorized into two categories. First category was 
age below 10 years (pediatric population) and 2 patients 
out of 36 infected cases belonged to this category while 11 
patients belonged to category of age above 60 years 
(geriatric population). 
Social habits 
Social habits were categorized into alcohol and smoking.1 
out of 36 infected patients was found to be a smoker, while, 
2 were found to be alcoholic. 
Graph 2 shows population distribution based on various 
patient related risk factor. 
Diabetes mellitus 
Diabetes mellitus was found to be a major risk factor. Out of 
36 infected surgical cases, 18 of them were found to be 
diabetic prior to the surgery. 
Chronic lung disease 
Chronic lung disease is also considered to be a risk factor 
associated with surgical site infection. Out of the total 
infected cases, 1 of the surgical cases was found to be 
suffering from chronic lung disease. 
Renal insufficiency 
Renal insufficiency is a contributing risk factor for surgical 
site infection. Out of the total infected cases, 1 of the 
surgical cases was found to be suffering from renal 
insufficiency. 
Immunosuppression 
Immunosuppression is one of a major risk factor associated 
with surgical site infection. Out of the total infected cases, 
13 patients were found to be suffering from immune-
suppression. 
Anemia 
Anemia is an important risk factor associated with surgical 
site infections. Out of the total infected cases, 12 patients 
were found to anemic prior to the surgery. 
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Figure 2: Population distribution based on various patient related risks 
 
Figure 3: Distribution of infected population based on various risk factors 
 
Graph 3 shows distribution of infected population based on 
various risk factors such as diabetes mellitus, chronic lung 
disease, immunosuppression, renal insufficiency, and anemia 
Surgery related risk factors 
The surgery related risk factors include the wound type, 
duration of surgery and use of implants. 
Wound type: 
The type of wound is considered to be an important risk 
factor that may be associated with the incidence of SSI. Out 
of 36 infected surgical cases, 34 of the patients had a clean 
type of wound while 2 patients had clean-contaminated type 
of wound. 
Duration of the surgery: 
Duration of surgery is a risk factor for the incidence of an SSI 
with respect to frequency of antimicrobial prophylaxis 
administered and its half-life. The duration of surgery was 
categorized into 0-3 hours and more than 3 hours. Out of the 
total infected cases 15 surgical procedures were completed 
with 3 hours of time while 21 surgical procedures took more 
than 3 hours for completion. 
Use of implants: 
Use of implants in surgical procedures is also considered to 
be a risk factor in patients especially those that are 
inherently at a higher risk. Out of the total infected cases, 8 
patients were found to have undergone implant surgery. 
 
Figure 4: distribution of infected population based on surgery related risk factors 
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Graph 4 shows distribution of infected population based on 
surgery related risk factors such as wound type, duration of 
surgery, and use of implants. 
Drug related risk factors 
Anti-microbial guidelines are designed in a way to prevent 
surgical site infection. It is necessary to comply with these 
guidelines before and after the surgical procedures. Out of 
the total infected cases, 19 cases did not comply with the 
guidelines. 
Frequency of administered antimicrobial agent plays a vital 
role in the prevention of surgical site infection. It is 
necessary to monitor the dose with respect to duration of 
surgery and half-life of the drug. Out of the total infected 
cases, only in 3 patients the antimicrobial prophylaxis was 
given more than once. 
 
 
Figure 5: Number of infected cases 
 
PHE criteria score 
The patients that reported an SSI were categorized into 
criteria based on Public Health England (PHE) scoring. The 
criteria were: 
1) Criteria 1- discharge pus + antibiotics prescribed. 
2) Criteria 2-clinical signs*+dehiscence 
3) Criteria 3-clinical signs*+antibiotics prescribed 
4) Criteria 4- Not applicable (includes only single symptom) 
 *Clinical signs-at least 2 of pain, heat, redness, or swelling. 
DISCUSSION 
Surgical Site infection is a well-known surgical complication. 
Strict asepsis, meticulous surgical techniques, less tissue 
handling, reducing the use cautery and use of prophylactic 
antibiotic have drastically reduced the incidence of SSI. In 
this study, on observation of 372 surgical cases, it was 
estimated that 1 in 10 patients acquired Surgical Site 
Infection within 30 days post-surgery. The possible causes of 
SSI in spite of administration of anti-microbial prophylaxis 
include: 
Gender: 
In this study, men were at higher risk for surgical site 
infection in comparison to the women population. This could 
be due to the differences in propensity for skin colonization 
or other anatomical differences. Although, gender 
differences in SSI exist and are procedure specific, the 
underlying mechanisms need to be further elucidated so that 
the targeted measures for the prevention of SSI can be 
developed. 
Age: 
Surgical site infections affect all the age groups and its 
incidence increases with the age. Older age group is 
considered a risk factor for development of SSI due to 
probable presence of comorbid conditions, impaired basic 
activities of daily living, cognitive impairment, frailty, use of 
multiple medications, nutritional status, reduced immune 
functionality and type of residence (nursing home). 
Weight: 
Obesity 
Excessive subcutaneous fat tissue predisposes obese 
patients to impaired healing due to low regional perfusion 
and oxygen tension. Secondly, there is increase in surgery 
time and a longer surgery time has been a significant 
predictor for postoperative wound infections. Furthermore 
impaired immunity, elevated blood glucose and too much 
tension on surgical incision are contributory factors to 
impaired healing. 
Malnutrition 
Nutrition depletion leads to malnutrition and impairs body 
resistance to infection. The various arms of defence system 
against infection require adequate nutrition for optimal 
function. In nutrition depletion this protection is impaired. 
Therefore, enhanced nutrition is required for improved 
immunological status. 
Comorbidites: 
Diabetes mellitus 
Patients with diabetes mellitus have a 50% higher chance of 
developing SSI than patients without diabetes. This is due to 
the altered cellular immune function. Pre and post-operative 
hyperglycaemia, elevated HbA1c level and history of 
diabetes mellitus adds on to the list of risk factor associated 
with SSI. 
Renal insufficiency 
It is observed that patients with chronic renal failure have an 
increased risk of SSI. This may be due to impaired host 
defences and wound healing. CKD and ESRD often occur in 
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older people who have limited physical mobility and 
predisposition for developing pressure related wounds. The 
common risk factor for impaired wound healing in CKD and 
ESRD patients includes poorly controlled DM, neuropathy, 
peripheral vascular disease, chronic venous insufficiency and 
aging. 
Chronic lung disease: 
Oxygen encourages the formation of collateral circulation 
(angiogenesis) and promotes wound contraction. Since in 
chronic lung disease both the quality and quantity of wound 
healing is limited. 
Immunosuppression: 
The body’s natural defence mechanism is the immune 
system. However in some conditions such as diabetes, 
chronic lung disease and carcinoma have a negative impact 
on the body’s ability to fight infection. For example, high 
blood sugar levels can cause the immune cells to function 
ineffectively, thereby raising the risk of infection. 
Dysfunction and apoptosis of anti-tumor effector cells in the 
tumor bearing host, creates and immune imbalance. 
Anaemia: 
The wound healing process relies completely on 
oxygenation. Therefore, low oxygen levels caused by 
anaemia can halt or slow down the wound healing stages, 
which leave patients more susceptible to wound infection. 
Social habits: 
Smoking 
Smoking is an important risk factor for SSI. It is known that 
smoking can lead to wound healing deficiencies. Tobacco use 
inhibits fibroblast proliferation by direct action of nicotine, 
as well as decreases collagen production and angiogenesis 
delaying the healing time. 
Alcohol use (more than 4 drinks per day) 
The routine use of alcohol is another important risk factor 
for SSI. The exact mechanism by which this factor increases 
the risk is unknown, but it is known that alcohol affects 
numerous physiological functions including, hemostasis, 
body immunity, cardio vascular and central nervous system. 
Wound type 
The degree of risk of an SSI is linked to the type of surgical 
wound present. Clean wounds are wounds that are not 
inflamed or contaminated and do not involve operating an 
internal organ while clean contaminated wounds have no 
evidence of infection at the time of surgery but do involve 
operating on an internal organ, so therefore, increasing the 
risk of causing a surgical site infection. 
Duration of surgery 
Duration of surgery is an independent risk factor for the 
development of SSI. Procedures requiring more time usually 
relate to complex cases and may involve extensile exposures 
and considerable tissue damage. Another factor contributing 
to the infection related to the surgical sites is the half-life of 
the drug. 
Implants 
Surgical implants constitute an essential component of 
modern medicine. Escalating use of surgical implants, 
particularly in patients inherently at high risk of infections, 
has magnified the importance of infectious complications. 
Infections associated with surgical implants are generally 
more cumbersome to manage, have a greater adverse impact 
on quality of life, result in excessive prolongation of hospital 
stay and incur excessive costs. 
Drug related 
Anti-microbial guidelines are carefully designed to meet the 
needs of major infection prophylaxis. It is of utmost 
importance to follow these guidelines and deviation from 
these guidelines may result in post-operative infections. 
Frequency and dose of the prophylactic antibiotics must be 
similar to the guidelines and in some cases must be tailored 
to the specific needs of the patients. Such special cases when 
the frequency and dose of the drug is patient specific are: if 
the duration of the surgery is longer than the usual or if the 
half-life of the drug is shorter, etc. 
CONCLUSION 
The study was conducted in an NABH accredited Quaternary 
Care Hospital in Bengaluru, Karnataka revealed that the SSIs 
are caused due to various risk factors and improper selection 
and re-dosing of antimicrobial prophylaxis. This can be 
prevented by considering the risk factors and appropriate 
selection of antimicrobial prophylaxis prior to surgery. 
Conclusively, it can be said that the incidence of surgical site 
infection varies from different patient and procedure factors 
as well as prophylactic antibiotic properties. They 
particularly show greater association to age, gender, certain 
comorbidities (like Diabetes mellitus, chronic lung disease, 
and renal insufficiency), and duration of surgery, 
administration of prophylactic antibiotics, frequency, timing 
and dose. Therefore, greater care must be taken for every 
specific patient and procedure and also choice of antibiotic 
prophylaxis. Thus, the study is aimed at identification of 
people at risk for SSIs and implementation of preventive 
strategies. Also, measures must be taken to improve health 
related quality of life and reduce the personal and economic 
burden of the patient with SSIs. Future prospective studies 
are therefore necessary to gather more accurate information 
in this regard. 
The study results helped in creating awareness amongst 
healthcare professionals regarding high incidence of SSI in 
spite of well-structured antimicrobial prophylactic 
guidelines. Therefore, evidence based, patient specific 
antimicrobial prophylaxis has to be customised in order to 
prevent the occurrence of surgical site infection. 
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